Literature DB >> 12517831

Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls.

Richard J Jurevic1, Mai Bai, Robert B Chadwick, Theodore C White, Beverly A Dale.   

Abstract

beta-Defensins are cationic antimicrobial peptides expressed in epithelia. They exhibit antibacterial, antifungal, and antiviral properties. Defensins are a component of the innate immune response, and it has been proposed that they have a protective role in the oral cavity. Previous studies have shown that human beta-defensin 1 (hBD-1) is constitutively expressed in oral epithelial cells but that expression varies between individuals. We tested the hypothesis that genetic variations in defensin peptide expression may be associated with opportunistic infections. This may be critical in the immunocompromised patient population, in which innate immune responses may have a relatively more important role. Oral Candida carriage status and the presence of six single-nucleotide polymorphisms (SNPs) in the DEFB1 gene encoding hBD-1 were evaluated in type I diabetic patients (n = 43) and nondiabetic controls (n = 50). Genomic DNA was obtained from buccal swabs. Portions of the DEFB1 gene were amplified, and each SNP was analyzed by a TaqMan assay, standardized with control DNA of known genotype. Candida carriage status was determined from unstimulated saliva on CHROMagar plating medium. A low level of Candida carriage was defined as < or = 350 CFU/ml. A high level of Candida carriage was seen in 44% of the diabetic subjects but only in 28% of the nondiabetic controls (P < 0.05). C. albicans predominated; however, diabetic subjects, especially those with high levels of carriage, showed an increased proportion of Candida glabrata and C. tropicalis. There was a strong association between an SNP in the 5' untranslated region (C-->G at position -44) and Candida carriage in both groups. Among individuals in the diabetic population who had the SNP allele 2 (G), 58% had low CFU, while 6% had high CFU. The C-->G SNP at position -44 is associated with low levels of Candida carriage. The resultant odd ratios are statistically significant for a protective effect (odd ratios, 25 for diabetic subjects and 8.5 for nondiabetic subjects). These results indicate that genetic variations in the DEFB1 gene encoding hBD-1 may have a major role in mediating and/or contributing to susceptibility to oral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517831      PMCID: PMC149626          DOI: 10.1128/JCM.41.1.90-96.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

Review 1.  The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents.

Authors:  V T Andriole
Journal:  J Antimicrob Chemother       Date:  1999-08       Impact factor: 5.790

2.  Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status.

Authors:  R Goswami; V Dadhwal; S Tejaswi; K Datta; A Paul; R N Haricharan; U Banerjee; N P Kochupillai
Journal:  J Infect       Date:  2000-09       Impact factor: 6.072

3.  Increase of Candida cell virulence by anticancer drugs and irradiation.

Authors:  E Ueta; T Tanida; K Yoneda; T Yamamoto; T Osaki
Journal:  Oral Microbiol Immunol       Date:  2001-08

4.  A peptide antibiotic from human skin.

Authors:  J Harder; J Bartels; E Christophers; J M Schröder
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 5.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 6.  Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans.

Authors:  M K Hostetter
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

7.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Discovery of five conserved beta -defensin gene clusters using a computational search strategy.

Authors:  Brian C Schutte; Joseph P Mitros; Jennifer A Bartlett; Jesse D Walters; Hong Peng Jia; Michael J Welsh; Thomas L Casavant; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

9.  Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism.

Authors:  Raffaella Circo; Barbara Skerlavaj; Renato Gennaro; Antonio Amoroso; Margherita Zanetti
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

10.  Polymorphisms of the human beta-defensin-1 gene.

Authors:  T Dörk; M Stuhrmann
Journal:  Mol Cell Probes       Date:  1998-06       Impact factor: 2.365

View more
  57 in total

Review 1.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

2.  Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon.

Authors:  Laurent Peyrin-Biroulet; Julia Beisner; Guoxing Wang; Sabine Nuding; Sajit Thottathil Oommen; Denise Kelly; Erika Parmentier-Decrucq; Rodrigue Dessein; Emilie Merour; Philipe Chavatte; Teddy Grandjean; Aude Bressenot; Pierre Desreumaux; Jean-Frédéric Colombel; Béatrice Desvergne; Eduard F Stange; Jan Wehkamp; Mathias Chamaillard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

3.  Are children with type 1 diabetes immunocompromised?

Authors:  Shareef Mustapha; Elizabeth Sellers; Heather Dean
Journal:  CMAJ       Date:  2005-08-16       Impact factor: 8.262

4.  A case of bilateral endophthalmitis and carriage of beta-defensin 1 44CC genotype.

Authors:  James Carter; Amanda J Churchill; Chris Gorman; Richard Haynes
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

Review 5.  Host defense peptides in the oral cavity and the lung: similarities and differences.

Authors:  G Diamond; N Beckloff; L K Ryan
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

Review 6.  Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa.

Authors:  Eric L Campbell; Sean P Colgan
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

7.  Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species.

Authors:  Whasun O Chung; Beverly A Dale
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Novel hairpin-shaped primer assay to study the association of the -44 single-nucleotide polymorphism of the DEFB1 gene with early-onset periodontal disease.

Authors:  Michele Boniotto; Manzour Hernando Hazbón; William James Jordan; Greig Patrick Lennon; Joyce Eskdale; David Alland; Grant Gallagher
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes.

Authors:  Andrea A Kalus; L Page Fredericks; Beth M Hacker; Henrik Dommisch; Richard B Presland; Janet R Kimball; Beverly A Dale
Journal:  BMC Oral Health       Date:  2009-08-27       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.